Nicolab
↗Amsterdam, Netherlands
Nicolab is a pioneering healthcare technology company founded in 2015 following the landmark MR CLEAN clinical trial. The company focuses on developing AI-powered clinical decision support systems to improve stroke diagnosis, triage, and management. Their flagship product, StrokeViewer, is a cloud-native, AI-driven platform that enables clinicians to analyze imaging, coordinate care across hospital networks, and make faster treatment decisions in acute stroke settings.
Headquartered in Amsterdam, the company operates globally with a mission to make expert stroke care available anywhere, anytime. Nicolab’s solutions are designed by physicians for physicians, integrating seamlessly into existing hospital infrastructure to streamline emergency workflows and reduce the time-to-treatment for stroke patients.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Digital Health
Sub-Industry:AI-powered medical imaging / Stroke care
SIZE & FINANCIALS
Employees:1-50
Founded:2015
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A
Modalities:AI-powered imaging analysis, Cloud-based workflow software
Active Trials:0
Trial Phases:-
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Key Partnerships:Harrison.ai (Launch partner for the Harrison.ai Open Platform to expand access to StrokeViewer)
COMPETITION
Position:Emerging
Competitors:Viz.ai, Aidoc, RapidAI
LEADERSHIP
Key Executives:
Michael Macilquham - CEO
LINKS
Website:nicolab.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Nicolab and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Nicolab. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.